Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis

BMC Pulmonary Medicine

Volumn 15, Issue 1, 2015, Pages

  Kaunisto, Jaana ^a,b   Kelloniemi, K ^c   Sutinen, E ^c   Hodgson, U ^c   Piilonen, A ^c   Kaarteenaho, R ^d,e,f,g   Makitaro R ^d,e   Purokivi, M ^g   Lappi Blanco, E ^e,h   Saarelainen, S ⁱ   Kankaanranta, H ^j,k   Mursu, A ^h   Kanervisto, M ^k   Salomaa, E R ^b   Myllarniemi M ^c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e MEDICAL RESEARCH CENTER OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

^h OULU UNIVERSITY HOSPITAL   (Finland)

ⁱ TAMPERE UNIVERSITY HOSPITAL   (Finland)

^j SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

more..

Author keywords

Epidemiology; Idiopathic pulmonary fibrosis; Register

Indexed keywords

CONTRAST MEDIUM;

AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE REGISTRY; FEMALE; FIBROSING ALVEOLITIS; FINLAND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ICD-10; IMAGE QUALITY; LUNG BIOPSY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOLOGIST; PATIENT ASSESSMENT; PREDICTION; PREVALENCE; PULMONOLOGIST; RADIODIAGNOSIS; RADIOLOGIST; SEX DIFFERENCE; SMOKING HABIT; THORAX RADIOGRAPHY; CLINICAL TRIAL; FOLLOW UP; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MEASUREMENT ACCURACY; MEDICAL RECORD; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; UNIVERSITY HOSPITAL; X-RAY COMPUTED TOMOGRAPHY;

AGED; DATA ACCURACY; FEMALE; FINLAND; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MALE; MEDICAL RECORDS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939642911     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-015-0074-3     Document Type: Article

References (25)

1. Kaunisto J, Salomaa ER, Hodgson U, Kaarteenaho R, Myllärniemi M. Idiopathic pulmonary fibrosis-a systematic review on methodology for the collection of epidemiological data. BMC Pulm Med. 2013;13:53.
2. King Jr TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083-92.
3. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071-82.
4. Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J. 2015. doi: 10.1183/09031936.00217614 .
5. Guenther A, European IPF Network. The European IPF Network: towards better care for a dreadful disease. Eur Respir J. 2011;37:747-8.
6. Moodley Y, Goh N, Glaspole I, Macansh S, Walters EH, Chapman S, et al. Australian idiopathic pulmonary fibrosis registry: vital lessons from a national prospective collaborative project. Respirology. 2014;19:1088-91.
7. Ryerson CJ, Corte TJ, Collard HR, Richeldi L. A global registry for idiopathic pulmonary fibrosis: the time is now. Eur Respir J. 2014;44:273-6.
8. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.
9. Agabiti N, Porretta MA, Bauleo L, Coppola A, Sergiacomi G, Fusco A, et al. Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:191-7.
10. King Jr TE, Albera C, Bradford WZ, Costabel U, du Bois RM, Leff JA, et al. All-cause mortality rate in patients with idiopathic pulmonary fibrosis: implications for the design and execution of clinical trials. Am J Respir Crit Care Med. 2014;189:825-31.
11. Atkins CP, Loke YK, Wilson AM. Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials. Respir Med. 2014;108:376-87.
12. Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med. 2011;184:842-7.
13. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155:242-8.
14. Hyldgaard C, Hilberg O, Bendstrup E. How does comorbidity influence survival in idiopathic pulmonary fibrosis? Respir Med. 2014;108:647-53.
15. King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001;164:1171-81.
16. Viljanen AA, Halttunen PK, Kreus K-E, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest. 1982;42:5-20.
17. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697-722.
18. Tzilas V, Bouros D. Inherent weaknesses of the current ICD coding system regarding idiopathic pulmonary fibrosis. Eur Respir J. 2015;45:1194-619.
19. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med. 2014;2:566-72.
20. Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002;57:338-42.
21. Watadani T, Sakai F, Johkoh T, Noma S, Akira M, Fujimoto K, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology. 2013;266:936-44.
22. Arakawa H, Honma K. Honeycomb lung: history and current concepts. AJR Am J Roentgenol. 2011;196:773-82.
23. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2011;66:462-7.
24. Ekström M, Gustafson T, Boman K, Nilsson K, Tornling G, Murgia N et al. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open. 2014; doi: 10.1136/bmjopen-2013-004018 .
25. Statistics Finland, official statistics of Finland. Available at: http://www.stat.fi/tup/suoluk/suoluk_vaesto.html . Date last updated 22 March 2013, date last accessed 30 December 2013.